ArticleMolecular biology reports2022
Apigenin alleviates resistance to doxorubicin in breast cancer cells by acting on the JAK/STAT signaling pathway.
Marwah Suliman Maashi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it